Summary of adverse events
| Grade* | Adverse event |
| 1 | Abdominal distension |
| 1 | ↑Alkaline phosphatase |
| 1 | ↑ALT |
| 1 | ↑aPTT |
| 1 | ↑AST |
| 1 | Chills |
| 3 | Dehydration |
| 2 | Diarrhea |
| 1 | Edema (LE) |
| 2 | Fatigue† |
| 3 | Fever† |
| 2 | Hyperbilirubinemia |
| 3 | Hyperglycemia |
| 3 | Hypertension |
| 2 | Hypoalbuminemia |
| 3 | Hypokalemia |
| 1 | Hypomagnesemia |
| 3 | Hyponatremia |
| 3 | Hypophosphatemia |
| 2 | Hypotension |
| 1 | ↑INR |
| 2 | Pulmonary edema |
| 2 | Rigors |
| 1 | Tachycardia |
| 1 | Thrombocytopenia |
*Highest grade experienced for each event noted.
†Led to 25% IL-2 dose reduction.
ALT, alanine aminotransferase; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase; IL-2, interleukin-2; INR, international normalized ratio.